AASLD GUIDELINES Bundle (free trial)

Acute Liver Failure

AASLD GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/100166

Contents of this Issue

Navigation

Page 6 of 13

Autoimmune Hepatitis ����Consider patients with coagulopathy and mild hepatic encephalopathy due to autoimmune hepatitis for corticosteroid treatment (prednisone, 40-60 mg/day) (III). ����Perform liver biopsy when autoimmune hepatitis is suspected as the cause of acute liver failure and autoantibodies are negative (III). ����Consider for transplantation patients with autoimmune hepatitis even while corticosteroids are being administered (III). Ischemic Injury ����In ALF patients with evidence of ischemic injury, cardiovascular support is the treatment of choice (III). Hepatic Vein Thrombosis ����Hepatic vein thrombosis with acute hepatic failure is an indication for liver transplantation, provided underlying malignancy is excluded (II-3). Wilson Disease ����To exclude Wilson disease one should obtain ceruloplasmin, serum and urinary copper levels, slit lamp examination for Kayser-Fleischer rings, hepatic copper levels when liver biopsy is feasible, and total bilirubin/alkaline phosphatase ratio (III). Note: Patients in whom Wilson disease is the likely cause of acute liver failure must be promptly considered for liver transplantation (III). Malignancy ����In patients with acute liver failure who have a previous cancer history or massive hepatomegaly, consider underlying malignancy and obtain imaging and liver biopsy to confirm or exclude the diagnosis (III). Central Nervous System ����Cerebral edema and intracranial hypertension (ICH) have long been recognized as the most serious complications of acute liver failure. Table 3. Grades of Encephalopathy Grade Definition I Changes in behavior with minimal change in level of consciousness II Gross disorientation, drowsiness, possibly asterixis, inappropriate behavior III Marked confusion; incoherent speech, sleeping most of the time but arousable to vocal stimuli IV Comatose, unresponsive to pain, decorticate or decerebrate posturing Note: some patients will overlap grades; clinical judgment is required. Adapted from Conn HO, Leevy CM, Vhlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology. 1977;72:573-583. 5

Articles in this issue

Archives of this issue

view archives of AASLD GUIDELINES Bundle (free trial) - Acute Liver Failure